Literature DB >> 20001406

Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review.

Diana Lima Villela1, Vera Lúcia C G Santos.   

Abstract

The aim of topical wound treatment is to favor efficient, rapid, and safe healing. The platelet-rich plasma (PRP) has been used for wound treatment since it contains various platelet growth factors. The objective of the present study was to collect evidence regarding the use of PRP for the topical treatment of chronic leg ulcers. For this purpose, a systematic review of the literature was performed according to the steps recommended by the Cochrane Collaboration with studies published until July 2008. Among 18 selected studies, 7 (39%) of these studies were randomized clinical. Five of the seven randomized clinical trials studied ulcers of diabetic etiology. The results of meta-analysis showed that PRP favors the healing process (95% CI: 2.94-20.31). In conclusion, the present systematic review and meta-analysis show that there is a scientific evidence regarding favorable outcomes of the use of PRP for the treatment of diabetic ulcer.

Entities:  

Mesh:

Year:  2010        PMID: 20001406     DOI: 10.3109/08977190903468185

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  28 in total

1.  SIMTI recommendations on blood components for non-transfusional use.

Authors:  Giuseppe Aprili; Giorgio Gandini; Roberto Guaschino; Laura Mazzucco; Laura Salvaneschi; Stefania Vaglio
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  Autologous derived, platelet-rich plasma gel in the treatment of nonhealing diabetic foot ulcer: a case report.

Authors:  Torsten Slesaczeck; Hartmut Paetzold; Thomas Nanning; Andreas Reichel; Andreas Barthel; Stefan Bornstein; Matthias Weck
Journal:  Ther Adv Endocrinol Metab       Date:  2012-04       Impact factor: 3.565

3.  Use of platelet-rich plasma to facilitate wound healing.

Authors:  Yuliya Menchisheva; Ulmeken Mirzakulova; Rudolf Yui
Journal:  Int Wound J       Date:  2018-11-15       Impact factor: 3.315

4.  Autologous Adipose-Derived Stem Cell (Adsc) Transplantation In The Management Of Chronic Wounds.

Authors:  T N Dung; V D Han; G N Tien; H Q Lam
Journal:  Ann Burns Fire Disasters       Date:  2021-12-31

Review 5.  The Diabetic Foot: A Historical Overview and Gaps in Current Treatment.

Authors:  Caroline C L M Naves
Journal:  Adv Wound Care (New Rochelle)       Date:  2016-05-01       Impact factor: 4.730

Review 6.  Emerging drugs for the treatment of diabetic ulcers.

Authors:  Francesco Tecilazich; Thanh L Dinh; Aristidis Veves
Journal:  Expert Opin Emerg Drugs       Date:  2013-05-21       Impact factor: 4.191

7.  Neuropathic ulcers in leprosy treated with intralesional platelet-rich plasma.

Authors:  Elena Conde-Montero; Celia Horcajada-Reales; Petunia Clavo; Irene Delgado-Sillero; Ricardo Suárez-Fernández
Journal:  Int Wound J       Date:  2014-09-08       Impact factor: 3.315

8.  The phagocytic fitness of leucopatches may impact the healing of chronic wounds.

Authors:  K Thomsen; H Trøstrup; L Christophersen; R Lundquist; N Høiby; C Moser
Journal:  Clin Exp Immunol       Date:  2016-03-23       Impact factor: 4.330

9.  Recalcitrant cutaneous ulcer of comorbid patient treated with platelet rich plasma: a case report.

Authors:  Dai Hyun Kim; Jong Yeob Kim; Soo Hong Seo; Hyo Hyun Ahn; Young Chul Kye; Jae Eun Choi
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

10.  Adjunct methods of the standard diabetic foot ulceration therapy.

Authors:  Dariusz Waniczek; Andrzej Kozowicz; Małgorzata Muc-Wierzgoń; Teresa Kokot; Elżbieta Swiętochowska; Ewa Nowakowska-Zajdel
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.